MIT engineers have developed a tiny implantable device that could revolutionize emergency treatment for people with Type 1 ...

Hypoglycemia – a condition in which low blood glucose levels can cause you to feel dizzy, weak, and shaky – can catch you by ...

The Department of Chemistry and Molecular Biology conducts high-quality research and education in the areas of chemical sciences and molecular life sciences.

A new study led by Ananda Basu, M.D., used novel non-radioactive, stable glucagon tracers for the first time to characterize glucagon metabolism in humans with and without Type 1 diabetes ...

Holst, Habener, and Drucker — who joined Habener’s lab in the mid-1980s — went on to characterize the biology and mechanism of GLP-1. They showed that food intake prompts the gut to release the ...

Glucagon prescriptions for severe hypoglycemia rose in Medicaid beneficiaries with the introduction of newer products but likely met only a fraction of the high-risk population’s needs.

The focus of my talk will be to address a conceptual new frame for glucagon biology known as the liver-alpha cell axis and how this physiological feedback system is disrupted by obesity causing a ...

Tests in mice suggest glucagon micelle could be used as a responsive system to prevent the onset of insulin-induced deep hypoglycemia.

The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.

Harvard Medical School researcher Joel Habener has won the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that has become the ...

This research on combining insulin with glucagon is being conducted by Michael A. Weiss, M.D., Ph.D., and his team at Indiana University, along with Raimund Herzog, M.D., and colleagues at Yale School ...

WebMD explains how the hormone glucagon helps balance your blood sugar and treat hypoglycemia.